These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36827064)

  • 1. A systematic review and meta-analysis of the diagnostic value of circulating microRNA-17-5p in patients with non-small cell lung cancer.
    Hao J; Shen Z
    Medicine (Baltimore); 2023 Feb; 102(8):e33070. PubMed ID: 36827064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapy.
    Li LL; Qu LL; Fu HJ; Zheng XF; Tang CH; Li XY; Chen J; Wang WX; Yang SX; Wang L; Zhao GH; Lv PP; Zhang M; Lei YY; Qin HF; Wang H; Gao HJ; Liu XQ
    Oncotarget; 2017 Jul; 8(28):45399-45414. PubMed ID: 28514730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA-145 as a diagnostic biomarker for non-small-cell lung cancer: A systemic review and meta-analysis.
    Tao S; Ju X; Zhou H; Zeng Q
    Int J Biol Markers; 2020 Dec; 35(4):51-60. PubMed ID: 33103527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of microRNA-25 in patients with non-small cell lung cancer in Chinese population: A systematic review and meta-analysis.
    Li C; Sun L; Zhou H; Yang Y; Wang Y; She M; Chen J
    Medicine (Baltimore); 2020 Dec; 99(51):e23425. PubMed ID: 33371070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-340 and MicroRNA-450b-5p: Plasma Biomarkers for Detection of Non-Small-Cell Lung Cancer.
    Wu Y; Jing H; Zhang J
    J Environ Public Health; 2022; 2022():8024700. PubMed ID: 36531335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
    Wang RJ; Zheng YH; Wang P; Zhang JZ
    Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of microRNA-148/152 family in non-small-cell lung cancer (NSCLC): A systematic review and meta-analysis.
    Cheng L; Li Q; Tan B; Ma D; Du G
    Medicine (Baltimore); 2021 Dec; 100(48):e28061. PubMed ID: 35049226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
    Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
    Luo J; Shen L; Zheng D
    Sci Rep; 2014 Sep; 4():6269. PubMed ID: 25201768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
    Zhang Y; Zhang Y; Yin Y; Li S
    Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
    Zhang Z; Yan S; Cui H; Chen H; Liu J
    Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-185 Is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer.
    Liu J; Han Y; Liu X; Wei S
    Technol Cancer Res Treat; 2020; 19():1533033820973276. PubMed ID: 33251978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
    Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
    Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of circulating microRNAs in non-small cell lung carcinoma.
    Baranwal H; Mishra SK; Kumari N; Singh S; Krishnani N; Nath A; Neyaz Z
    Indian J Pathol Microbiol; 2024 Jul; 67(3):502-509. PubMed ID: 38391370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of microRNAs as potential non-invasive biomarkers for detecting non-small cell lung cancer: a meta-analysis.
    Wang H; Wu S; Zhao L; Zhao J; Liu J; Wang Z
    Respirology; 2015 Jan; 20(1):56-65. PubMed ID: 25440223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined panel of circulating microRNA as a diagnostic tool for detection of the non-small cell lung cancer.
    Abdollahi A; Rahmati S; Ghaderi B; Sigari N; Nikkhoo B; Sharifi K; Abdi M
    QJM; 2019 Oct; 112(10):779-785. PubMed ID: 31236600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.